Irina Mihaela Esanu, Irina Cotea, Mihaela Boanca, Cringuta Paraschiv
Our research was aimed at determining whether a hemodynamic guided treatment could contribute to a better hypertension control in patients suffering from metabolic syndrome, by choosing the best specific therapy for each patient depending on his/her hemodynamic profile. We monitored the evolution of both the patient’s blood pressure and hemodynamic profile under anti-hypertension treatment, which we assessed using thoracic electrical bioimpedance (TEB). TEB examination, which is a both simple and noninvasive method, provides in just a few minutes precious information on the patient’s cardiac output and hemodynamic anomalies: vasoactivity, blood volume, inotropy and chronotropy. Material and methods The study was conducted on a group of 30 subjects, who were transport workers, suffering from metabolic syndrome and uncontrolled hypertension, and who declared treatment compliance. We monitored the evolution of both the patient’s blood pressure and hemodynamic profile under anti-hypertension treatment, which we assessed using TEB. For each patient, we recorded the percentage deviation of the hemodynamic parameters, whereas treatment modulation was done depending on the hemodynamic profile of each patient. Results According to our study results, hemodynamically guided anti-hypertension therapy improves the hypertension control rate. In our study, normal blood pressure was achieved, accompanied by normal dynamic status, which obviously led to better quality of life. Conclusions Our research supports the assumption according to which hypertension is associated with hemodynamic modulator disorders and it should therefore be treated as a hemodynamic origin condition and not as a mere rise in the blood pressure values.